Exploring the Role of GLP-1 Receptor Agonists in Ocular Disorders: An In-Depth Analysis of Existing Studies and Future Directions
By
Yu Luo
Yanting Xia
Xiaohong Gong
Meiling Hao
Qiping Wei
Liang Liao
January 8, 2026
Clinical Scorecard: Exploring the Role of GLP-1 Receptor Agonists in Ocular Disorders: An In-Depth Analysis of Existing Studies and Future Directions
At a Glance
Category Detail
Condition Key Mechanisms Expand to include specific neuroprotective and anti-inflammatory effects with references. Target Population Care Setting
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
A d d s p e c i f i c p a r a m e t e r s f o r v i s u a l a c u i t y a n d r e t i n a l h e a l t h a s s e s s m e n t s . Risks
Patient & Prescribing Data
Patients with diabetic retinopathy, glaucoma, and age-related macular degeneration
GLP-1RAs may provide additional benefits beyond glycemic control, including neuroprotection.
Clinical Best Practices
Related Resources & Content
